Endometriosis Epiomic Insights, 2015-2020
Epiomic Insights for Endometriosis provides you with a top line snapshot of the market potential for this chronic and debilitating disease. With many patients remaining asymptomatic, there is a challenge in obtaining the true prevalent patient population for Endometriosis.
Sourcing data from our Epiomic Patient segmentation database, we are able to reference relevant clinical trial data and patient registries to provide a picture of the total projected prevalent population across 7 major global markets.
This one-page synopsis developed by our team of analysts delivers a current overview of the disease and risk factors with a perspective on the future drivers of the patient population. Gender balance and disease stages are also displayed in easy to understand graphics.
This style of report is ideal for companies entering a new market segment or disease area of which they have limited knowledge. Alternatively, companies considering investing in healthcare innovation may benefit from a high-level, accurate overview of the market to determine likely commercial potential of such an investment.
Sourcing data from our Epiomic Patient segmentation database, we are able to reference relevant clinical trial data and patient registries to provide a picture of the total projected prevalent population across 7 major global markets.
This one-page synopsis developed by our team of analysts delivers a current overview of the disease and risk factors with a perspective on the future drivers of the patient population. Gender balance and disease stages are also displayed in easy to understand graphics.
This style of report is ideal for companies entering a new market segment or disease area of which they have limited knowledge. Alternatively, companies considering investing in healthcare innovation may benefit from a high-level, accurate overview of the market to determine likely commercial potential of such an investment.
